Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren C Cutmore

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancers|April 30, 2021
Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of CancerLauren C Cutmore, John F Marshall
Cancers|September 28, 2024
Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T CellsEman N Ahmed, Lauren C Cutmore, John F Marshall
Frontiers in Cell and Developmental Biology|September 12, 2022
Ligand-bound integrin αvβ6 internalisation and traffickingAmelia Meecham, Lauren C Cutmore, Pantelitsa Protopapa, et al.
Molecular Therapy. Oncology|June 30, 2026
Development of chimeric antigen receptors targeting the γδ T cell receptorLauren C Cutmore, Norris Lam, Christina Amatya, et al.
Molecular Therapy. Methods & Clinical Development|March 8, 2024
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemiaChristina Amatya, Katherine A Weissler, Vicki Fellowes, et al.
Journal for Immunotherapy of Cancer|February 17, 2026
Corticosteroids ameliorate CAR T-cell-induced cytokine-release syndrome without inhibiting multiple myeloma treatmentChristina Amatya, Katherine A Weissler, Norris Lam, et al.
Cancers|May 14, 2025
The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocompetent ModelZuoyi Zhao, Lauren C Cutmore, Renato B Baleeiro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 22, 2024
Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancerNicholas F Brown, Elizabeth R Murray, Lauren C Cutmore, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|April 30, 2021
Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of CancerLauren C Cutmore, John F Marshall
Cancers|September 28, 2024
Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T CellsEman N Ahmed, Lauren C Cutmore, John F Marshall
Frontiers in Cell and Developmental Biology|September 12, 2022
Ligand-bound integrin αvβ6 internalisation and traffickingAmelia Meecham, Lauren C Cutmore, Pantelitsa Protopapa, et al.
Molecular Therapy. Oncology|June 30, 2026
Development of chimeric antigen receptors targeting the γδ T cell receptorLauren C Cutmore, Norris Lam, Christina Amatya, et al.
Molecular Therapy. Methods & Clinical Development|March 8, 2024
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemiaChristina Amatya, Katherine A Weissler, Vicki Fellowes, et al.
Journal for Immunotherapy of Cancer|February 17, 2026
Corticosteroids ameliorate CAR T-cell-induced cytokine-release syndrome without inhibiting multiple myeloma treatmentChristina Amatya, Katherine A Weissler, Norris Lam, et al.
Cancers|May 14, 2025
The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocompetent ModelZuoyi Zhao, Lauren C Cutmore, Renato B Baleeiro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 22, 2024
Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancerNicholas F Brown, Elizabeth R Murray, Lauren C Cutmore, et al.
Pageof 1